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Abstract 
We illustrate the case of a 41-year-old male with allergic manifestations since childhood. 
He sought medical attention for intermittent, progressive dysphagia from which he had 
been suffering for a number of years, having felt the sensation of a retrosternal lump and 
a self-limited obstruction to the passage of food. Endoscopy detected a submucosal 
tumor in the upper third of the esophagus, which was typified, via biopsy, as a granular 
cell tumor with benign characteristics and probably responsible for the symptoms. Two 
years later, the patient sought medical attention once again as these symptoms had not 
abated, hence digestive endoscopy was repeated. This revealed stenosis of the junction 
between the middle and lower thirds of the organ which had not been detected 
previously but was passable under gentle pressure. Eosinophilic esophagitis was 
detected after biopsies were taken. Esophageal manometry identified a motor disorder 
affecting the esophageal body. Following three months of treatment using fluticasone 
propionate applied topically, the symptoms went into remission, esophageal stenosis 
disappeared and the esophageal biopsies returned to normal. This is the first 
documented case of the link between granular cell tumors and Eosinophilic esophagitis, 
two different disorders which could cause dysphagia in young patients. 
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Introduction 
Granular cell tumors were first described as myoblastoma by Abrikossof in 1926 [1]. 
This tumor is rare, usually benign and of neuroectodermic origin in the Schwann cells [2]. 
It has been described at multiple locations and is the second greatest cause of esophagheal 
mesenchymal tumors, after leiomyoma. Eosinophilic esophagitis (EE) is a 
clinicopathological entity which is allergic in origin and was characterised by Attwood in 
1993 [3]. Both processes can cause dysphagia via different mechanisms. This is the first 
documented case of a patient suffering from both entities, who was diagnosed via 
digestive endoscopy and biopsy. 
Case Report 
A 41-year-old male with a history of allergic asthma since childhood, rhinoconjunctivitis and 
sensitivity to pollen, attended the gastroenterology clinic having suffered from progressive dysphagia on 
an infrequent basis over a number of years. The patient described symptoms of a retrosternal lump, and 
felt as if something were blocking the passage of food in his esophagus. These episodes varied in length 
and subsided of their own accord after several minutes without requiring endoscopic intervention. The 
symptoms had recurred on a number of occasions and were not linked to any specific food type. He 
showed no signs of nausea, regurgitation, pyrosis, abdominal pain or weight loss. 
After an endoscopy was carried out, a tumor was detected in the upper third of the organ which was 
submucosal, yellowish in color, molar-shaped and hard to the touch using the biopsy tweezers. It 
measured approximately 5 mm, did not restrict the passage of the endoscope and was coated in normal 
mucosa (fig. 1). The biopsies showed that the submucosal esophageal stroma were infiltrated by nests of 
cells with ample, granular eosinophilic cytoplasms with central nuclei and showed no indication of 
atypia or mitosis, in line with esophageal granular cell tumor (fig. 2). The patient had similar symptoms 
to those related to this type of lesion, and because the tumor was small and the histology showed no 
indication of malignity, we decided to carry out endoscopic and histological monitoring. 
Two years later, the patient was still being attended for episodic dysphagia. During the endoscopic 
review, performed at that time, the submucosal tumor was once again detected in the upper third, 
showing no changes. Regular stenosis was also identified in the junction between the upper and middle 
esophageal thirds which had gone undetected during the previous exploration and was passable under 
gentle endoscopic pressure. The mucosa of the middle and distal esophagus appeared edematous with a 
loss of normal vascular pattern and had various longitudinal striae along the folds. The biopsies taken 
from this area showed epithelial edema, acanthosis and papillomatosis, with dense eosinophilic 
leucocyte infiltration, by more than 24 eosinophils per high-power field, findings compatible with EE 
(fig. 3). Biopsies were also taken of the tumor in the upper third which still seemed to be benign. The 
rest of the stomach and duodenum exploration was normal and the biopsies taken from the antral 
mucosa did not show any alterations. 
The patient was subjected to an ambulatory 24-hour pH-metry, which ruled out pathological 
gastroesophageal reflux as a possible cause of eosinophilic infiltration of the esophagus, and a stationary 
esophageal manometry was also performed with the following results: upper esophageal sphincter with 
normal pressure and pharyngeal coordination, normal pressure and complete relaxation of the lower 
sphincter. The esophageal body had 20% non-transmitted waves in the 3/3, 10% non-transmitted waves 
in the upper 2/3 with normal amplitude in the distal third and 70% peristaltic waves of normal duration 
with increased amplitude in the distal third. 
Upon diagnosis of EE, treatment of topical fluticasone propionate was administered, applied on the 
tongue using an inhaler device and then swallowed, at a dosage of 500 μg every 12 h. The patient was 
recommended not to eat and drink for several hours after the application of treatment and to rinse out 
his mouth with water and bicarbonate of soda 20 min after taking the medication. He was subsequently 
referred to the allergy clinic to be examined for possible sensitivity to food or airborne allergens. 
After three months of treatment, the patient showed substantial clinical improvement and the 
episodes of dysphagia had subsided. The esophageal mucosa had returned to normal (except for the 
tumor in the upper third) and the mucosal biopsies showed resolution of the eosinophilic infiltrate and 
of the histological changes. The manometry which was repeated following treatment showed  
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normalisation of the motor function of the esophagus, with 100% peristaltic waves of normal duration 
and amplitude in the three thirds. 
Discussion 
Endoscopic exploration is a basic technique in the study of dysphagia. In young 
patients, it is mainly caused by benign disorders associated with acid reflux exposure, 
leading to very rare malignant neoplasias. In recent years, we have witnessed a 
considerable rise in the number of reported cases of EE [4], to the extent that this 
emerging entity should also be included in the differential diagnosis of dysphagia, 
especially in young patients with a background of allergies [5]. Granular cell tumor or 
Abrikossoff’s tumor is a rare lesion deriving from the Schwann cells of the submucosal 
plexus neurons of the esophagus of which less than 300 cases have been documented. 
Most reported cases have involved single lesions located in the distal third, mainly 
affecting women in their fifties [6], characteristics which were not met by our patient. 
Although this pathology is usually benign, a few exceptional cases of malignant tumors 
have been reported, with distant ganglionary metastasis, and these required obligatory 
histological analysis to rule out this possibility. Certain instances of granular cell tumors 
synchronically or metachronically linked to malignant neoplasias of the esophagus have 
also been documented, such as adenocarcinomas or squamous carcinomas [7–9], 
although the actual extent of this association is unknown. 
To date, no cases of granular cell tumors linked to EE have been reported, meaning 
that our case is the first. Nevertheless, because both disorders suffered by the patient are 
unrelated in origin (mucosal hypersensitivity and tumoral proliferation of Schwann cells), 
we believe that association is coincidental. 
Given that most esophageal granular cell tumors are small (<1 cm), diagnosis tends to 
occur accidentally during endoscopic exploration carried out for another purpose. From 
the start, our patient’s symptoms definitely matched those of EE, but because information 
on this entity has only recently become available and endoscopic findings are often not 
very obvious, going undetected by the non-expert, it is likely that the patient’s initial 
diagnosis was incorrect. 
EE can be associated with a wide range of endoscopic patterns, including concentric, 
focal or segmentary stenosis, simultaneous contractions, rings along the organ or subtle 
findings described regarding the mucosal appearance. A recent review has established that 
the most common endoscopic findings described in the literature linked to EE were white 
stipple-like exudates, linear fissures and reddening, but mucosa was regarded as normal 
in near a quarter of patients [10]. The extensive polymorphism on the endoscopic 
findings characterizing EE was classified in a recent work according to a manometric and 
histopathological relationship [11]: Alterations in the esophageal calibre can be related 
with motor disturbances affecting the two distal thirds of the organ, while varying degrees 
of intensity in histological damage induced by activation and degranulation of 
eosinophilic leukocytes lead to different endoscopic patterns, which could be classified in 
4 well-defined categories: granular, corrugated, undulated and exudative. 
As regards treatment alternatives for EE, both dietetic and pharmacological measures 
have proven efficient. Children following basic diets (lacking in antigenic capacity) over 
an 8-week period showed improved symptoms in addition to histological normalisation 
[12]. Because this measure is difficult to apply to adults, we decided to opt for 
pharmacological treatment for our patient. Among these options, systemic action  
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glucocorticoids [13, 14] proved to be efficient given clinical, endoscopic and histological-
type parameters, although they have potential side effects. Topical corticoids such as 
fluticasone propionate administered by inhaler are effective and, compared to systemic 
corticoids, do not have any side effects and are widely used to treat EE in children [15–19] 
and adults [20, 21]. Although some reports discuss the use of sodium cromoglycate and 
antileukotrienes [22, 23] in the treatment of EE, these cases are isolated due to limited 
experience. After 3 months of treatment with fluticasone propionate, we noticed 
considerable improvement in symptoms such as remission of dysphagia, less time 
required in having lunch and dinner, as well as resolution of the esophageal inflammatory 
infiltrate and normalisation of epithelial histological changes. Manometric alterations of 
the esophagus reverted following treatment, as proof of their functional nature. 
Possible therapeutic alternatives for granular cell tumors include endoscopic 
resectioning of the lesion using a variety of procedures [6], surgical resectioning and an 
expectant or conservative approach [24] to endoscopic and biopsy monitoring every 6 to 
12 months. The latter attitude is the most frequently adopted in literature and is that 
which is currently recommended for lesions which are generally benign and where 
malignisation is rare. Provided that the tumor fulfils certain benign criteria, in that it is 
small (<10 mm), asymptomatic, does not have a histology of mitosis or dysplasia or 
changes in size, periodic monitoring can be employed, as this is the safest option with the 
best cost/efficiency relationship. Considering these characteristics, we adopted a 
conservative approach towards the Abrikossoff’s tumor identified in our patient. 
To conclude, this is the first documented case of the link between granular cell tumors 
and EE. Although both entities are lesions of a different nature and physiopathological 
origin, they are both interesting pathologies that should be considered during the 
endoscopic examination of dysphagia in young patients. 
 
 
 
 
 
Fig. 1. Endoscopic image of our case, which shows a millimetric and yellowish ‘molar-like’ nodule 
located in the upper esophagus, impressed into the submucosa. 
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Fig. 2. Tissue preparation within which tumor proliferation nests or cords may be observed, 
immediately below the esophageal epithelium showing signs of hyperplasia with acanthosis and 
papillomatosis (HE 200×). 
 
 
 
Fig. 3. Biopsy taken over the distal esophageal third, showing regenerative changes expressed like 
hyperplasia of basal cells and acanthosis, into epithelium containing intercellular edema and 
eosinophilic infiltration (HE 200×). 
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